Brain Tumor Imaging in Clinical Trials

References

1. ↵
   Batchelor T, Stanley K, Andersen J. Clinical trials in neuro-oncology. Curr Opin Neurol 2001;14:689–94

   CrossRefPubMedWeb of Science
2. ↵
   Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981;47:207–14

   CrossRefPubMedWeb of Science
3. ↵
   Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205–16

   Abstract/FREE Full Text
4. ↵
   Macdonald DR, Cascino TL, Schold SC, et al. Response criteria for phase II studies of malignant glioma. J Clin Oncol 1990;8:1277–80

   Abstract
5. ↵
   Galanis E, Buckner JC, Maurer MJ, et al. Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods. Neuro Oncol 2006;8:156–65

   Abstract/FREE Full Text
6. ↵
   Hess KR, Wong ET, Jaeckle KA, et al. Response and progression in recurrent malignant glioma. Neuro Oncol 1999;1:282–88

   Abstract/FREE Full Text
7. ↵
   Shah GD, Kesari S, Xu R, et al. Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas. Neuro Oncol 2006;8:38–46

   Abstract/FREE Full Text
8. ↵
   Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1989;10:1–10

   CrossRefPubMedWeb of Science
9. ↵
   Sorensen AG, Patel S, Harmath C, et al. Comparison of diameter and perimeter methods for tumor volume calculation. J Clin Oncol 2001;19:551–57

   Abstract/FREE Full Text
10. ↵
    Warren KE, Patronas N, Aikin AA, et al. Comparison of one-, two-, and three-dimensional measurements of childhood brain tumors. J Natl Cancer Inst 2001;93:1401–05

    Abstract/FREE Full Text
11. ↵
    Ulmer S, Mavrakis A, Barker FG, et al. Incidence of multifocal lesions in malignant glioma as detected by MRI. Neurology 2006;66:A431
12. ↵
    Forsyth PA, Petrov E, Mahallati H, et al. Prospective study of postoperative magnetic resonance imaging in patients with malignant gliomas. J Clin Oncol 1997;15:2076–81

    Abstract/FREE Full Text
13. ↵
    Ulmer S, Braga TA, Barker FG, et al. Clinical and radiographic features of peritumoral infarction following resection of glioblastoma. Neurology 2006;67:1668–70

    Abstract/FREE Full Text
14. ↵
    Smith JS, Cha S, Mayo MC, et al. Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury. J Neurosurg 2005;103:428–38

    CrossRefPubMedWeb of Science
15. ↵
    Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998;90:1473–79

    Abstract/FREE Full Text
16. ↵
    Prados MD, Seiferheld W, Sandler HM, et al. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. Int J Radiat Oncol Biol Phys 2004;58:1147–52

    CrossRefPubMed
17. ↵
    Grant R, Liang BC, Slattery J, et al. Chemotherapy response criteria in malignant glioma. Neurology 1997;48:1336–40

    Abstract/FREE Full Text
18. ↵
    Ballman KV, Buckner JC, Brown PD, et al. The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme. Neuro Oncol 2007;9:29–38

    Abstract/FREE Full Text
19. ↵
    Pope WB, Lai A, Nghiemphu P, et al. MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy. Neurology 2006;66:1258–60

    Abstract/FREE Full Text
20. ↵
    Mills SJ, Patankar TA, Haroon HA, et al. Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? AJNR Am J Neuroradiol 2006;27:853–58

    Abstract/FREE Full Text